Evaluation of Vitamin B 12 Monitoring in Veterans With Type 2 Diabetes on Metformin Therapy

Abstract

Background:

Studies have shown an association between metformin use and vitamin B₁₂ deficiency. Since 2017, the American Diabetes Association (ADA) Standards of Medical Care in Diabetes Guideline has included a recommendation for periodic vitamin B₁₂ measurements in metformin-treated patients, especially those with anemia or peripheral neuropathy.

Objective:

To determine the overall incidence and impact of the ADA Guideline on vitamin B₁₂ monitoring in a veteran population on long-term metformin therapy.

Methods:

Retrospective chart review was performed for patients on metformin who started therapy prior to 2005 at the VA North Texas Health Care System (VANTXHCS). The primary outcome was the proportion of patients with at least 1 vitamin B₁₂ level drawn during 2016 versus 2018. Metformin dose and duration, vitamin B₁₂ supplementation, and incident neuropathy prescriptions or diagnosis were also analyzed.

Results:

Of 394 patients included for the primary outcome, 136 (34.5%) had at least 1 vitamin B₁₂ level in 2016 versus 198 (50.3%) patients in 2018 (odds ratio: 1.94, P < .001). Of the 394 patients, 157 were diagnosed with neuropathy or prescribed a medication for neuropathy without a vitamin B₁₂ level in the previous year or with a low level that was not supplemented.

Conclusion:

Vitamin B₁₂ monitoring significantly increased between 2016 and 2018, aligning with the release of the 2017 ADA guidelines. However, a large proportion of patients were identified who were diagnosed with or treated for neuropathy without adequate vitamin B₁₂ monitoring.

Keywords

type 2 diabetes metformin

Get full access to this article

View all access options for this article.

References

American Diabetes Association. Standards of medical care in diabetes—2017. J Clin Appl Res Educ. 2017;40(suppl 1):S33–S43. doi:10.2337/dc17-S007.

Garber

Abrahamson

Barzilay

, et al. AACE/ACE Consensus Statement. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm—2016 executive summary. Endocr Pract. 2016;22(1):84–113. doi:10.4158/EP151126.CS.

Department of Veteran Affairs, Department of Defense. VA/DoD clinical practice guideline for the management of diabetes mellitus. Washington, DC: Department of Veteran Affairs, Department of Defense; 2010:146.

Center for Disease Control and Prevention. National Diabetes Statistics Report, 2017 Estimates of Diabetes and Its Burden in the United States Background. 2017. https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. Accessed April 8, 2019.

Liu

Sayam

Shao

, et al. Prevalence of and trends in diabetes among veterans, United States, 2005-2014. Prev Chronic Dis. 2017;14:170230. doi:10.5888/pcd14.170230.

Wheeler

Moore

Forsberg

, et al. Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy. Diabetologia. 2013;56(9):1934–1943. doi:10.1007/s00125-013-2958. -1.

Singh

Kumar

Karmakar

, et al. Association of B12 deficiency and clinical neuropathy with metformin use in type 2 diabetes patients. J Postgrad Med. 2013;59(4):253–257. doi:10.4103/0022-3859.123143.

Kancherla

Elliott

Patel

, et al. Long-term metformin therapy and monitoring for vitamin B12 deficiency among older veterans. J Am Geriatr Soc. 2017;65(5):1061–1066. doi:10.1111/jgs.14761.

GLUCOPHAGE®. 1995. https://packageinserts.bms.com/pi/pi_glucophage.pdf. Accessed April 8, 2019.

10.

de Jager

Kooy

Lehert

, et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ. 2010;340:c2181. doi:10.1136/bmj.c2181.

11.

Aroda

Edelstein

Goldberg

, et al. Long-term metformin use and vitamin B12 deficiency in the diabetes prevention program outcomes study. J Clin Endocrinol Metab. 2016;101(4):1754–1761. doi:10.1210/jc.2015-3754.

12.

Pflipsen

Saguil

, et al. The prevalence of vitamin B12 deficiency in patients with type 2 diabetes: a cross-sectional study. J Am Board Fam Med. 2009;22(5):528–534. doi:10.3122/jabfm.2009.05.090044.

13.

Liu

Quan

, et al. Vitamin B12 status in metformin treated patients: systematic review. PLoS One. 2014;9(6):e100379. doi:10.1371/journal.pone.0100379.

14.

Chapman

Darling

Brown

. Association between metformin and vitamin B₁₂ deficiency in patients with type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab. 2017;42(5):316–327. doi:10.1016/j.diabet.2016.03.008.

15.

Niafar

Hai

Porhomayon

, et al. The role of metformin on vitamin B12 deficiency: a meta-analysis review. Intern Emerg Med. 2015;10(1):93–102. doi:10.1007/s11739-014-1157-5.

16.

Pierce

Chung

Black

. Evaluation of vitamin B12 monitoring in a veteran population on long-term, high-dose metformin therapy. Ann Pharmacother. 2012;46(11):1470–1476. doi:10.1345/aph.1R223.

17.

Tomkin

Hadden

Weaver

, et al. Vitamin-B12 status of patients on long-term metformin therapy. Br Med J. 1971;2(5763):685–687. http://www.ncbi.nlm.nih.gov/pubmed/5556053. Accessed April 8, 2019.

18.

S-H

Ahn

Y-B

, et al. Association of vitamin B12 deficiency and metformin use in patients with type 2 diabetes. J Korean Med Sci. 2014;29(7):965–972. doi:10.3346/jkms.2014.29.7.965.

19.

Reinstatler

Williamson

, et al. Association of biochemical B 12 deficiency with metformin therapy and vitamin B 12 supplements: the national health and nutrition examination survey, 1999-2006. Diabetes Care. 2012;35(2):327–333. doi:10.2337/dc11-1582.

20.

Beulens

JWJ

Hart

Kuijs

, et al. Influence of duration and dose of metformin on cobalamin deficiency in type 2 diabetes patients using metformin. Acta Diabetol. 2015;52(1):47–53. doi:10.1007/s00592-014-0597-8.

21.

de Groot-Kamphuis

van Dijk

Groenier

, et al. Vitamin B12 deficiency and the lack of its consequences in type 2 diabetes patients using metformin. Neth J Med. 2013;71(7):386–390. http://www.ncbi.nlm.nih.gov/pubmed/24038568. Accessed April 8, 2019.

22.

Ting

Szeto

Chan

, et al. Risk factors of vitamin B 12 deficiency in patients receiving metformin. Arch Intern Med. 2006;166(18):1975–1979.

23.

Bell

DSH

. Metformin-induced vitamin B12 deficiency presenting as a peripheral neuropathy. South Med J. 2010;103(3):265–267. doi:10.1097/SMJ.0b013e3181ce0e4d.

24.

Langan

Zawistoski

. Update on vitamin B12 deficiency. Am Fam Physician. 2011;83(12):1425–1430.

25.

Wile

Toth

. Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy. Diabetes Care. 2010;33(1):156–161. doi:10.2337/dc09-0606.

26.

Varela-Moreiras

Murphy

Scott

. Cobalamin, folic acid, and homocysteine. Nutr Rev. 2009;67(suppl 1):S69–S72. doi:10.1111/j.1753-4887.2009.00163.x.

27.

Biemans

Hart

Rutten

GEHM

, et al. Cobalamin status and its relation with depression, cognition and neuropathy in patients with type 2 diabetes mellitus using metformin. Acta Diabetol. 2014;52(2):383–393. doi:10.1007/s00592-014-0661-4.

28.

American Diabetes Association. Primary care—standards of medical care in diabetes. Diabetes Care. 2018;41(suppl 1):S1–S159. doi:10.2337/dc13-S011.

29.

American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(suppl 1):S90–S102. doi:10.2337/dc19-S009.

30.

Hanney

Castle-Clarke

Grant

, et al. How long does biomedical research take? Studying the time taken between biomedical and health research and its translation into products, policy, and practice. Health Res Policy Syst. 2015;13(1):1. doi:10.1186/1478-4505-13. -1.

31.

Hughes

McNulty

. Assessing biomarker status of vitamin B12in the laboratory: no simple solution. Ann Clin Biochem. 2018;55(2):188–189. doi:10.1177/0004563217747907.

32.

Green

. Review article vitamin B 12 deficiency from the perspective of a practicing hematologist. Blood. 2018;129(19):2603–2611. doi:10.1182/blood-2016-10-569186.In.